- Home
- VNDA vs JOF Comparison
VNDA vs JOF Comparison
Compare VNDA & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- JOF
- Stock Information
- Founded
- VNDA 2002
- JOF 1990
- Country
- VNDA United States
- JOF Japan
- Employees
- VNDA N/A
- JOF N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- JOF Trusts Except Educational Religious and Charitable
- Sector
- VNDA Health Care
- JOF Finance
- Exchange
- VNDA Nasdaq
- JOF Nasdaq
- Market Cap
- VNDA 270.0M
- JOF 217.9M
- IPO Year
- VNDA 2006
- JOF N/A
- Fundamental
- Price
- VNDA $4.51
- JOF $7.57
- Analyst Decision
- VNDA Strong Buy
- JOF
- Analyst Count
- VNDA 2
- JOF 0
- Target Price
- VNDA $15.50
- JOF N/A
- AVG Volume (30 Days)
- VNDA 499.8K
- JOF 43.9K
- Earning Date
- VNDA 02-05-2025
- JOF 01-01-0001
- Dividend Yield
- VNDA N/A
- JOF 3.33%
- EPS Growth
- VNDA N/A
- JOF N/A
- EPS
- VNDA N/A
- JOF N/A
- Revenue
- VNDA $190,858,000.00
- JOF N/A
- Revenue This Year
- VNDA $5.60
- JOF N/A
- Revenue Next Year
- VNDA $42.85
- JOF N/A
- P/E Ratio
- VNDA N/A
- JOF N/A
- Revenue Growth
- VNDA N/A
- JOF N/A
- 52 Week Low
- VNDA $3.46
- JOF $6.64
- 52 Week High
- VNDA $6.75
- JOF $8.04
- Technical
- Relative Strength Index (RSI)
- VNDA 42.95
- JOF 43.89
- Support Level
- VNDA $4.77
- JOF $7.44
- Resistance Level
- VNDA $4.95
- JOF $7.61
- Average True Range (ATR)
- VNDA 0.15
- JOF 0.12
- MACD
- VNDA -0.03
- JOF -0.01
- Stochastic Oscillator
- VNDA 31.82
- JOF 27.08
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.